Effect of Patient-Anesthesiologist Gender Concordance and Analgesia Method on Postoperative Pain in Mastectomy Patients
Launched by DR ABDURRAHMAN YURTASLAN ANKARA ONCOLOGY TRAINING AND RESEARCH HOSPITAL · Jun 16, 2025
Trial Information
Current as of June 27, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how the gender of the anesthesiologist (the doctor who manages pain and consciousness during surgery) and whether the patient and anesthesiologist share the same gender affect pain levels and pain medication needs after breast cancer surgery (mastectomy). The study also looks at how these factors might influence any complications during and after the surgery. The goal is to better understand if matching patient and anesthesiologist gender, along with the type of pain relief used, can improve recovery and comfort after surgery.
Women aged 18 or older who have breast cancer and are scheduled for a planned mastectomy may be eligible to join this study. Participants need to be in generally stable health and able to provide complete medical information before and after surgery. Emergency surgeries or other major procedures at the same time would exclude someone from participating. If you join, your care team will observe and record your pain levels and any complications related to anesthesia, helping doctors learn how to provide better pain relief and care tailored to each patient.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Female patients aged 18 years or older Diagnosed with breast cancer and scheduled for elective mastectomy ASA physical status classification I-III Complete availability of preoperative and postoperative data Voluntary written informed consent to participate in the study
- Exclusion Criteria:
- • Patients undergoing emergency surgery Incomplete or erroneous data records Patients undergoing concurrent major surgery
About Dr Abdurrahman Yurtaslan Ankara Oncology Training And Research Hospital
Dr. Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital is a leading institution dedicated to advancing cancer care and research in Turkey. With a strong focus on innovative oncology treatments and comprehensive training programs, the hospital serves as a pivotal center for clinical trials aimed at improving patient outcomes. Its multidisciplinary team of specialists collaborates to explore cutting-edge therapeutic approaches, ensuring adherence to the highest standards of clinical research and patient safety. The hospital's commitment to excellence positions it as a key player in the global oncology research landscape.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Ankara, Yenimahalle, Turkey
Patients applied
Trial Officials
Mustafa Kemal SAHIN, M.D
Principal Investigator
MUSTAFA KEMAL ŞAHİN
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported